NPI: 1013322726 · TACOMA, WA 98445 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 06/23/2014
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 06/23/2014 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 14,900 | $410K |
| 2019 | 20,458 | $500K |
| 2020 | 17,459 | $519K |
| 2021 | 13,613 | $434K |
| 2022 | 12,245 | $367K |
| 2023 | 6,669 | $408K |
| 2024 | 2,920 | $458K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 33,370 | 2,385 | $2.89M |
| A4657 | Syringe, with or without needle, each | 3,378 | 1,412 | $139K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 26,674 | 1,259 | $44K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 551 | 238 | $20K |
| J1756 | Injection, iron sucrose, 1 mg | 4,833 | 922 | $6K |
| J1270 | Injection, doxercalciferol, 1 mcg | 14,178 | 951 | $2K |
| 90674 | 96 | 72 | $367.00 | |
| G0008 | Administration of influenza virus vaccine | 110 | 83 | $67.59 |
| 85041 | 988 | 618 | $0.00 | |
| 82108 | 354 | 228 | $0.00 | |
| 85048 | 988 | 618 | $0.00 | |
| 83540 | 543 | 343 | $0.00 | |
| 83970 | 697 | 407 | $0.00 | |
| 82728 | 575 | 353 | $0.00 | |
| 83550 | 527 | 331 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 341 | 216 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 46 | 32 | $0.00 |
| 0012A | 15 | 13 | $0.00 |